A top Trump administration health official said last week that his agency will soon launch a novel program to have Medicare cover the costs of CBD for certain patients. But while the administration has not yet released specific details about the initiative’s rollout, one cannabis company that says it’s partnering with the government on the effort has since shed some light on what to expect.
At a White House event last week, President Donald Trump signed an executive order directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). But another major reform was also announced: A pilot program enabling eligible patients to access hemp-derived cannabidiol that’d be covered under federal health insurance plans, projected to launch by April.
Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services (CMS), spoke about the initiative at the signing ceremony, crediting Trump and U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for “pushing for change” and “relentlessly” pursuing an agenda rooted in a “deep passion for research.”
Oz said Trump called him “frequently” to discuss the potential benefits of CBD after hearing from friends who
Read full article on Marijuana Moment
